Literature DB >> 18689637

Passive immunity to West Nile virus provides limited protection in a common passerine species.

Nicole M Nemeth1, Paul T Oesterle, Richard A Bowen.   

Abstract

Passerine birds have played an important role in the establishment, maintenance, and spread of West Nile virus (WNV) in North America, and some are susceptible to WNV-associated mortality. Characterization of passive transfer of anti-WNV antibodies in passerines is important to understanding transmission and demographic effects of WNV on wild birds. We showed passively acquired maternal antibodies to WNV in the house sparrow (Passer domesticus). Although all seropositive females (N = 18) produced antibody-positive egg yolks, only 20% of seropositive mothers (3/15) produced seropositive chicks. The estimated average half-life of maternal antibodies in chick sera was 3 days, and no antibodies were detected after 9 days post-hatch (DPH). Maternal antibodies failed to provide protection against viremia in chicks at 21-25 DPH. Although the observed duration of persistence of passively inherited anti-WNV antibodies in house sparrows differs from some non-passerine birds, it remains unknown whether similar patterns occur in other passerines.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18689637

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  21 in total

1.  Maternal antibody persistence: a neglected life-history trait with implications from albatross conservation to comparative immunology.

Authors:  R Garnier; R Ramos; V Staszewski; T Militão; E Lobato; J González-Solís; T Boulinier
Journal:  Proc Biol Sci       Date:  2011-12-21       Impact factor: 5.349

2.  Ecological and life-history factors influencing the evolution of maternal antibody allocation: a phylogenetic comparison.

Authors:  Brianne Addison; Kirk C Klasing; W Douglas Robinson; Suzanne H Austin; Robert E Ricklefs
Journal:  Proc Biol Sci       Date:  2009-08-26       Impact factor: 5.349

3.  An enzootic vector-borne virus is amplified at epizootic levels by an invasive avian host.

Authors:  Valerie A O'Brien; Amy T Moore; Ginger R Young; Nicholas Komar; William K Reisen; Charles R Brown
Journal:  Proc Biol Sci       Date:  2010-08-04       Impact factor: 5.349

4.  West Nile virus in American White Pelican chicks: transmission, immunity, and survival.

Authors:  Marsha A Sovada; Pamela J Pietz; Erik K Hofmeister; Alisa J Bartos
Journal:  Am J Trop Med Hyg       Date:  2013-03-25       Impact factor: 2.345

5.  Are maternal antibodies really that important? Patterns in the immunologic development of altricial passerine house sparrows (Passer domesticus).

Authors:  Marisa O King; Jeb P Owen; Hubert G Schwabl
Journal:  PLoS One       Date:  2010-03-11       Impact factor: 3.240

6.  DNA vaccination of American robins (Turdus migratorius) against West Nile virus.

Authors:  A Marm Kilpatrick; Alan P Dupuis; Gwong-Jen J Chang; Laura D Kramer
Journal:  Vector Borne Zoonotic Dis       Date:  2010-05       Impact factor: 2.133

7.  Maternal antibody transfer can lead to suppression of humoral immunity in developing zebra finches (Taeniopygia guttata).

Authors:  Loren Merrill; Jennifer L Grindstaff
Journal:  Physiol Biochem Zool       Date:  2014-08-25       Impact factor: 2.247

8.  Ontogeny of adaptive antibody response to a model antigen in captive altricial zebra finches.

Authors:  Tess L Killpack; William H Karasov
Journal:  PLoS One       Date:  2012-10-09       Impact factor: 3.240

9.  A metapopulation model to simulate West Nile virus circulation in Western Africa, Southern Europe and the Mediterranean basin.

Authors:  Benoit Durand; Gilles Balança; Thierry Baldet; Véronique Chevalier
Journal:  Vet Res       Date:  2010-01-18       Impact factor: 3.683

10.  Usutu virus persistence and West Nile virus inactivity in the Emilia-Romagna region (Italy) in 2011.

Authors:  Mattia Calzolari; Paolo Bonilauri; Romeo Bellini; Alessandro Albieri; Francesco Defilippo; Marco Tamba; Massimo Tassinari; Antonio Gelati; Paolo Cordioli; Paola Angelini; Michele Dottori
Journal:  PLoS One       Date:  2013-05-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.